Joseph Mancias, MD, PhD, is focused on the study of pancreatic cancer, particularly the critical aspects of the biology of pancreatic cancer in order to develop novel therapeutic approaches. The Mancias Lab combines biochemical, quantitative mass spectrometry-based proteomic, gene editing, cell biological, and mouse modeling techniques to advance our understanding of pancreatic cancer.